5-DAY NONOBSERVED ARTESUNATE MONOTHERAPY FOR TREATING UNCOMPLICATED FALCIPARUM MALARIA IN YOUNG GABONESE CHILDREN

Norbert Georg Schwarz, Sunny Oyakhirome, Marc Pötschke, Benjamin Gläser, Peter Klein Klouwenberg, Handan Altun, Ayôla Akim Adégnika, Saadou Issifou, Jutta Kun, Peter G. Kremsner,

American Journal of Tropical Medicine and Hygiene · 2005 · 18 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

Despite different recommendations from WHO and national authorities, artesunate monotherapy is increasingly used for treating African children with malaria. A 5-day course of oral artesunate (first day: 4 mg/kg body weight, observed intake; and 2 mg/kg body weight on the following days with nonobserved drug intake) yielded a PCR-corrected Day 28 cure rate of 90% (45 of 50 patients; CI 78-97%) in Gabonese children aged between 2 and 18 months. Artesunate was well tolerated, and no severe adverse events were reported.

References

21